Brian Taft, PA
Medical · Coeur D Alene, IDNPI 1184142606
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $1,053, more than ten times the $32 reported in 2022.
Across 79 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$559
- Corcept Therapeutics$125
- Otsuka America Pharmaceutical, Inc.$107
- Novartis$82
- Amgen$79
- Lilly USA, LLC$65
- plus $521 from 15 others
What the payments were for
- Food & beverage$1,539100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $559 |
| Corcept Therapeutics | 6 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Novartis | 3 | $82 |
| Amgen | 3 | $79 |
| Lilly USA, LLC | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
| Exact Sciences | 3 | $57 |
| Boston Scientific | 2 | $55 |
| Novo Nordisk | 3 | $47 |
| Johnson & Johnson | 3 | $46 |
| Merck | 2 | $46 |
| AstraZeneca | 2 | $32 |
| Edwards Lifesciences | 1 | $29 |
| Coopersurgical, Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
How this compares
$1,539 in reported general payments places this provider in the 75th percentile of 265 medical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $28,366 |
| EliquisApixaban | 26 | $27,770 |
| JardianceEmpagliflozin | 24 | $22,459 |
| FarxigaDapagliflozin Propanediol | 27 | $21,102 |
| JanuviaSitagliptin Phosphate | 12 | $6,586 |
| XareltoRivaroxaban | 11 | $5,243 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,113 |
| Celecoxib | 25 | $1,519 |
| Atorvastatin Calcium | 144 | $1,504 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,317 |
| Tamsulosin Hcl | 71 | $1,153 |
| Losartan Potassium | 98 | $993 |
| Duloxetine Hcl | 35 | $984 |
| Amlodipine Besylate | 120 | $854 |
| Levothyroxine Sodium | 136 | $850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $47 | $28,36631 claims |
| PfizerEliquis | $22 | $27,77026 claims |
| AstraZenecaFarxiga | $32 | $21,10227 claims |
| MerckJanuvia | $46 | $6,58612 claims |
| Johnson & JohnsonXarelto | $46 | $5,24311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 265 medical providers in Idaho.
Other medical in Coeur D Alene
- Mark MartindaleCoeur D Alene$5K
- Richard WiesemannCoeur D Alene$3K
- Cody ReeseCoeur D Alene$3K
- Gretchen FoleyCoeur D Alene$3K
- Heather SarkisCoeur D Alene$3K
- Reagan SnowCoeur D Alene$2K
- Brett ZundelTerreton$71K
- Jessica BishopBoise$60K
- Kyle GeorgeMeridian$19K
- Jed BartschiIdaho Falls$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.